[ccp4bb] Synthetic RNA for Crystallization

2011-03-13 Thread Michael Thompson
Hello All,

I am looking for some advice from some experienced RNA crystallographers. I 
would like to order some relatively short (90 bases) synthetic RNAs for 
crystallization trials. I was wondering if anyone could comment on the use of 
synthetic RNAs for crystallization. Specifically, what is the longest synthetic 
RNA that can be used for crystallization trials? I've seen some structures in 
the PDB that are up to 88 bases and are reported to have been obtained with 
synthetic constructs (3OWI - glycine riboswitch), but I don't really know if 
that's routine or if it's an exceptional case. Also, for those who have 
experience with the use of synthetic RNAs, I was wondering where people 
generally order their synthetic constructs from? Our resident expert in RNA 
crystallography recommended a company called Dharmacon (part of ThermoFisher), 
but I was hoping that I might get some other opinions as to which companies 
make the best quality oligonucleotides, provide samples with the highest 
purity, and have the most reasonable prices.

Thanks in advance for the help!

Mike



-- 
Michael C. Thompson

Graduate Student

Biochemistry  Molecular Biology Division

Department of Chemistry  Biochemistry

University of California, Los Angeles

mi...@chem.ucla.edu


Re: [ccp4bb] Synthetic RNA for Crystallization

2011-03-13 Thread Israel Sanchez
Hi Michael,


we normally produce synthetic RNAs following this classic paper if the size
is more than let say 40-50 nucleotide, otherwise we buy the RNAs from
Dharmacon and the quality is totally OK.

Hope it helps



javascript:AL_get(this,%20'jour',%20'J%20Mol%20Biol.');

J Mol Biol. javascript:AL_get(this,%20'jour',%20'J%20Mol%20Biol.'); 1995
Jun 2;249(2):398-408.
Crystallization of RNA-protein complexes. I. Methods for the large-scale
preparation of RNA suitable for crystallographic studies.

Price SRhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Price%20SR%22%5BAuthor%5D,
Ito N http://www.ncbi.nlm.nih.gov/pubmed?term=%22Ito%20N%22%5BAuthor%5D,
Oubridge
C http://www.ncbi.nlm.nih.gov/pubmed?term=%22Oubridge%20C%22%5BAuthor%5D,
Avis
JM http://www.ncbi.nlm.nih.gov/pubmed?term=%22Avis%20JM%22%5BAuthor%5D, Nagai
K http://www.ncbi.nlm.nih.gov/pubmed?term=%22Nagai%20K%22%5BAuthor%5D.

MRC Laboratory of Molecular Biology, Cambridge, UK.
Abstract

In vitro transcription using bacteriophage RNA polymerases and linearised
plasmid or oligodeoxynucleotide templates has been used extensively to
produce RNA for biochemical studies. This method is, however, not ideal for
generating RNA for crystallisation because efficient synthesis requires the
RNA to have a purine rich sequence at the 5' terminus, also the subsequent
RNA is heterogenous in length. We have developed two methods for the large
scale production of homogeneous RNA of virtually any sequence for
crystallization. In the first method RNA is transcribed together with two
flanking intramolecularly-, (cis-), acting ribozymes which excise the
desired RNA sequence from the primary transcript, eliminating the promoter
sequence and heterogeneous 3' end generated by run-off transcription. We use
a combination of two hammerhead ribozymes or a hammerhead and a hairpin
ribozyme. The RNA-enzyme activity generates few sequence restrictions at the
3' terminus and none at the 5' terminus, a considerable improvement on
current methodologies. In the second method the BsmAI restriction
endonuclease is used to linearize plasmid template DNA thereby allowing the
generation of RNA with any 3' end. In combination with a 5' cis-acting
hammerhead ribozyme any sequence of RNA may be generated by in vitro
transcription. This has proven to be extremely useful for the synthesis of
short RNAs.


2011/3/13 Michael Thompson mi...@chem.ucla.edu

 Hello All,

 I am looking for some advice from some experienced RNA crystallographers. I
 would like to order some relatively short (90 bases) synthetic RNAs for
 crystallization trials. I was wondering if anyone could comment on the use
 of synthetic RNAs for crystallization. Specifically, what is the longest
 synthetic RNA that can be used for crystallization trials? I've seen some
 structures in the PDB that are up to 88 bases and are reported to have been
 obtained with synthetic constructs (3OWI - glycine riboswitch), but I don't
 really know if that's routine or if it's an exceptional case. Also, for
 those who have experience with the use of synthetic RNAs, I was wondering
 where people generally order their synthetic constructs from? Our resident
 expert in RNA crystallography recommended a company called Dharmacon (part
 of ThermoFisher), but I was hoping that I might get some other opinions as
 to which companies make the best quality oligonucleotides, provide samples
 with the highest purity, and have the most reasonable prices.

 Thanks in advance for the help!

 Mike



 --
 Michael C. Thompson

 Graduate Student

 Biochemistry  Molecular Biology Division

 Department of Chemistry  Biochemistry

 University of California, Los Angeles

 mi...@chem.ucla.edu




-- 
 Israel Sanchez Fernandez PhD
Ramakrishnan-lab
MRC Laboratory of Molecular Biology,
Hills Road, Cambridge, CB2 0QH, UK


Re: [ccp4bb] I/sigmaI of 3.0 rule

2011-03-13 Thread George M. Sheldrick
Dear Boaz,

You are quite correct, 'latter' and 'former' need to be switched in my 
email. Apologies to CCP4bb for the confusion caused!

Best wishes, George

Prof. George M. Sheldrick FRS
Dept. Structural Chemistry,
University of Goettingen,
Tammannstr. 4,
D37077 Goettingen, Germany
Tel. +49-551-39-3021 or -3068
Fax. +49-551-39-22582


On Sun, 13 Mar 2011, Boaz Shaanan wrote:

 Dear George,
 
 While I agree with you I wonder whether in this statement:
 
 ...The practice of quoting R-values both
 for all data and for F4sigma(F) seems to me to be useful. For example
 if the latter is much larger than the former, maybe you are including a
 lot of weak data...
 
 Shouldn't it be: ...former (i.e. R for all data) is much larger than the 
 latter (i.e. R for F4sigma(F)... ?
 Just wondering, although it could be my late night misunderstanding.
 
Best regards,
 
 Boaz
 
 Boaz Shaanan, Ph.D.
 Dept. of Life Sciences
 Ben-Gurion University of the Negev
 Beer-Sheva 84105
 Israel
 
 Phone: 972-8-647-2220  Skype: boaz.shaanan
 Fax:   972-8-647-2992 or 972-8-646-1710
 
 
 
 
 From: CCP4 bulletin board [CCP4BB@JISCMAIL.AC.UK] On Behalf Of George M. 
 Sheldrick [gshe...@shelx.uni-ac.gwdg.de]
 Sent: Sunday, March 13, 2011 12:11 AM
 To: CCP4BB@JISCMAIL.AC.UK
 Subject: Re: [ccp4bb] I/sigmaI of 3.0 rule
 
 Dear James,
 
 I'm a bit puzzled by your negative R-values and unstable behavior. In
 practice, whether we refine against intensity or against |F|, it is
 traditional to quote an R-factor (called R1 in small molecule
 crystallography) R = Sum||Fo|-|Fc|| / Sum|Fo|. Reflections that have
 negative measured intensities are either given F=0 or (e.g. using
 TRUNCATE) F is set to a small positive value, both of which avoid having
 to take the square root of a negative number which most computers don't
 like doing. Then the 'divide by zero' catastropy and negative R-values
 cannot happen because Sum|Fo| is always significantly greater than zero,
 and in my experience there is no problem in calculating an R-value even
 if the data are complete noise. The practice of quoting R-values both
 for all data and for F4sigma(F) seems to me to be useful. For example
 if the latter is much larger than the former, maybe you are including a
 lot of weak data. Similarly in calculating merging R-values, most
 programs replace negative intensities by zero, again avoiding the
 problems you describe.
 
 Best wishes, George
 
 Prof. George M. Sheldrick FRS
 Dept. Structural Chemistry,
 University of Goettingen,
 Tammannstr. 4,
 D37077 Goettingen, Germany
 Tel. +49-551-39-3021 or -3068
 Fax. +49-551-39-22582
 
 
 On Sat, 12 Mar 2011, James Holton wrote:
 
 
  The fundamental mathematical problem of using an R statistic on data with
  I/sigma(I)  3 is that the assumption that the fractional deviates 
  (I-I)/I
  obey a Gaussian distribution breaks down.  And when that happens, the R
  calculation itself becomes unstable, giving essentially random R values.
  Therefore, including weak data in R calculations is equivalent to 
  calculating
  R with a 3-sigma cutoff, and then adding a random number to the R value.  
  Now,
  random data is one thing, but if the statistic used to evaluate the data
  quality is itself random, then it is not what I would call useful.
 
  Since I am not very good at math, I always find myself approaching 
  statistics
  by generating long lists of random numbers, manipulating them in some way, 
  and
  then graphing the results.  For graphing Rmerge vs I/sigma(I), one does find
  that Bernhard's rule of Rmerge = 0.8/( I/sigma(I) ) generally applies, but
  only for I/sigma(I) that is = 3.  It gets better with high multiplicity, 
  but
  even with m=100, the Rmerge values for the I/sigma(I)  1 points are all 
  over
  the place.  This is true even if you average the value of Rmerge over a
  million random number seeds.  In fact, one must do so much averaging, 
  that I
  start to worry about the low-order bits of common random number generators. 
   I
  have attached images of these Rmerge vs I/sigma graphs.  The error bars
  reflect the rms deviation from the average of a large number of Rmerge
  values (different random number seeds).  The missing values are actually
  points where the average Rmerge in 60 trials (m=3) was still negative.
 
  The reason for this noisy R factor problem becomes clear if you consider 
  the
  limiting case where the true intensity is zero, and make a histogram of ( 
  I
  - I )/I.  It is not a Gaussian.  Rather, it is  the Gaussian's evil
  stepsister: the Lorentzian (or Cauchy distribution).  This distribution 
  may
  look a lot like a Gaussian, but it has longer tails, and these tails give it
  the weird statistical property of having an undefined mean value.  This is
  counterintuitive!  Because you can clearly just look at the histogram and 
  see
  that it has a central peak (at zero), but if you generate a million
  

Re: [ccp4bb] Automating liquid dispensing

2011-03-13 Thread Dr. Isabel De Moraes
The Liquidator 96 is at my opinion the best in the market. Is a manual system, 
but fast without problems related to cross contamination.
The electronic ones  (from other brands) at some point gives you problems with 
the electroninc system and the tips are not disposable (they take  long time 
between plates due to the tip washes). 
 
Regards,
Isabel
-

Dr. Isabel De Moraes, MRSC

Membrane Protein Laboratory Facilities Co-ordinator/Group Leader
Membrane Protein Laboratory,
Diamond Light Source Ltd,
Harwell Science and Innovation Campus,
Chilton, Didcot, Oxfordshire,
OX11 ODE, UK

Tel: 01235 778664
email: isabel.de-mor...@diamond.ac.uk

http://www.diamond.ac.uk/Science/MPL/default.htm
http://www.rc-harwell.ac.uk/

---



From: CCP4 bulletin board on behalf of Jim Fairman
Sent: Fri 3/11/2011 10:57 PM
To: CCP4BB@JISCMAIL.AC.UK
Subject: Re: [ccp4bb] Automating liquid dispensing


We also recently obtained a Liquidator 96 from Rainin.  Working well so far and 
way below the price of any of the competitors.


On Fri, Mar 11, 2011 at 5:41 PM, Engin Özkan eoz...@stanford.edu wrote:


Dear Stephen,

I did start a similar thread about a year ago. If you want to see the 
posts, check this out and the responses to it:

http://www.mail-archive.com/ccp4bb@jiscmail.ac.uk/msg14758.html

In my case, the winner was the Liquidator 96 from Rainin. It has proven 
to be very useful and too popular, and now it is being utilized for everything 
under the sun.

Best,
Engin

On 3/11/11 2:00 PM, Stephen McMahon wrote:


Hi -
We are in the market for a new liquid handling robot 
specifically for dispensing custom 96 well crystallisation screens.
What are people using these days? Likes / dislikes?
Many thanks,
Stephen




-- 
Engin Özkan
Post-doctoral Scholar
Howard Hughes Medical Institute
Dept of Molecular and Cellular Physiology
279 Campus Drive, Beckman Center B173
Stanford School of Medicine
Stanford, CA 94305
ph: (650)-498-7111





-- 
Jim Fairman, Ph D.
Post-Doctoral Fellow
National Institutes of Health - NIDDK 
The Buchanan Lab http://www-mslmb.niddk.nih.gov/buchanan/index.html 
Lab: 1-301-594-9229
E-mail: fairman@gmail.com james.fair...@nih.gov


Re: [ccp4bb] I/sigmaI of 3.0 rule

2011-03-13 Thread Phil Evans
You do also have always to consider why you are doing this calculation -
usually to satisfy a sceptical and possibly ill-informed referee. A major
reason for doing this is to justify including an outer resolution shell of
data (see this BB passim), and for this I have come to prefer the random
half-dataset correlation coefficient in shells. A CC has a more
straightforward distribution than an R-factor (though not entirely without
problems). It is independent of the SD estimates, and easy to understand.

Phil


 The fundamental mathematical problem of using an R statistic on data
 with I/sigma(I)  3 is that the assumption that the fractional deviates
 (I-I)/I obey a Gaussian distribution breaks down.  And when that
 happens, the R calculation itself becomes unstable, giving essentially
 random R values.  Therefore, including weak data in R calculations is
 equivalent to calculating R with a 3-sigma cutoff, and then adding a
 random number to the R value.  Now, random data is one thing, but if
 the statistic used to evaluate the data quality is itself random, then
 it is not what I would call useful.

 Since I am not very good at math, I always find myself approaching
 statistics by generating long lists of random numbers, manipulating them
 in some way, and then graphing the results.  For graphing Rmerge vs
 I/sigma(I), one does find that Bernhard's rule of Rmerge = 0.8/(
 I/sigma(I) ) generally applies, but only for I/sigma(I) that is = 3.
 It gets better with high multiplicity, but even with m=100, the Rmerge
 values for the I/sigma(I)  1 points are all over the place.  This is
 true even if you average the value of Rmerge over a million random
 number seeds.  In fact, one must do so much averaging, that I start to
 worry about the low-order bits of common random number generators.  I
 have attached images of these Rmerge vs I/sigma graphs.  The error
 bars reflect the rms deviation from the average of a large number of
 Rmerge values (different random number seeds).  The missing values
 are actually points where the average Rmerge in 60 trials (m=3) was
 still negative.

 The reason for this noisy R factor problem becomes clear if you
 consider the limiting case where the true intensity is zero, and make
 a histogram of ( I - I )/I.  It is not a Gaussian.  Rather, it is
 the Gaussian's evil stepsister: the Lorentzian (or Cauchy
 distribution).  This distribution may look a lot like a Gaussian, but
 it has longer tails, and these tails give it the weird statistical
 property of having an undefined mean value.  This is counterintuitive!
 Because you can clearly just look at the histogram and see that it has a
 central peak (at zero), but if you generate a million
 Lorentzian-distributed random numbers and take the average value, you
 will not get anything close to zero.  Try it!  You can generate a
 Lorentzian deviate from a uniform deviate like this:
 tan(pi*(rand()-0.5)), where rand() makes a random number from 0 to 1.

 Now, it is not too hard to understand how R could blow up when the
 true spot intensities are all zero.  After all, as I approaches
 zero, the ratio ( I - I ) / I approaches a divide-by-zero problem.
 But what about when I/sigma(I) = 1?  Or 2?  If you look at these
 histograms, you find that they are a cross between a Gaussian and a
 Lorentzian (the so-called Voigt function), and the histogram does not
 become truly Gaussian-looking until I/sigma(I) = 3.  At this point,
 the R factor behaves Bernhard's rule quite well, even with
 multiplicities as low as 2 or 3.  This was the moment when I realized
 that the early crystallographers who first decided to use this 3-sigma
 cutoff, were smarter than I am.

 Now, you can make a Voigt function (or even a Lorentzian) look more like
 a Gaussian by doing something called outlier rejection, but it is hard
 to rationalize why the outliers are being rejected.  Especially in a
 simulation!  Then again, the silly part of all this is all we really
 want is the middle of the histogram of ( I - I )/I.  In fact, if
 you just pick the most common Rmerge, you would get a much better
 estimate of the true Rmerge in a given resolution bin than you would
 by averaging a hundred times more data.  Such procedures are called
 robust estimators in statistics, and the robust estimator
 equivalents to the average and the rms deviation from the average are
 the median and the median absolute deviation from the median.  If you
 make a list of Lorentzian-random numbers as above, and compute the
 median, you will get a value very close to zero, even with modest
 multiplicity!  And the median absolute deviation from the median
 rapidly converges to 1, which matches the full width at half maximum
 of the histogram quite nicely.

 So, what are the practical implications of this?  Perhaps instead of the
 average Rmerge in each bin we should be looking at the median Rmerge?
 This will be the same as the average for the cases where I/sigma(I)  3,
 but still be well 

Re: [ccp4bb] Synthetic RNA for Crystallization

2011-03-13 Thread Artem Evdokimov
1) Make your own with in vitro transcription (straight T7 r T7+RDRP like in
Finnzymes kit)
2) Buy from IDTDNA - they are very good

Long RNA tends to be expensive. Consider RNA ligase if two or more pieces
can be stitched together.

Artem
On Sun, Mar 13, 2011 at 3:39 AM, Michael Thompson mi...@chem.ucla.eduwrote:

 Hello All,

 I am looking for some advice from some experienced RNA crystallographers. I
 would like to order some relatively short (90 bases) synthetic RNAs for
 crystallization trials. I was wondering if anyone could comment on the use
 of synthetic RNAs for crystallization. Specifically, what is the longest
 synthetic RNA that can be used for crystallization trials? I've seen some
 structures in the PDB that are up to 88 bases and are reported to have been
 obtained with synthetic constructs (3OWI - glycine riboswitch), but I don't
 really know if that's routine or if it's an exceptional case. Also, for
 those who have experience with the use of synthetic RNAs, I was wondering
 where people generally order their synthetic constructs from? Our resident
 expert in RNA crystallography recommended a company called Dharmacon (part
 of ThermoFisher), but I was hoping that I might get some other opinions as
 to which companies make the best quality oligonucleotides, provide samples
 with the highest purity, and have the most reasonable prices.

 Thanks in advance for the help!

 Mike



 --
 Michael C. Thompson

 Graduate Student

 Biochemistry  Molecular Biology Division

 Department of Chemistry  Biochemistry

 University of California, Los Angeles

 mi...@chem.ucla.edu



Re: [ccp4bb] Synthetic RNA for Crystallization

2011-03-13 Thread Mario Sanches
Hi Mike,

For long RNAs ( 40bases), in vitro transcription is the method of choice.
You might want to take a look at this introductory page from Ambion:

http://www.ambion.com/techlib/basics/transcription/index.html

For structural studies you will have to scale up to milliliter scale. For
that you might want to produce your own T7 RNA polymerase. Another thing to
consider is the method of purification of your RNA. I believe purification
from denaturing gel is the most widely used method, but you should consider
native chromatographic purification as well. The following references should
get you started on the subject:

http://www.ncbi.nlm.nih.gov/pubmed/20946782
http://www.ncbi.nlm.nih.gov/pubmed/17272845

If you absolutely want to go with chemical synthesis, I believe you will
have to buy shorter RNA pieces (40 bases or less) and ligate them later
using a T4 RNA ligase. There are many good references out there that deal
with production, purification and crystallization or RNA.

Good luck,

Mario Sanches


On Sun, Mar 13, 2011 at 4:39 AM, Michael Thompson mi...@chem.ucla.eduwrote:

 Hello All,

 I am looking for some advice from some experienced RNA crystallographers. I
 would like to order some relatively short (90 bases) synthetic RNAs for
 crystallization trials. I was wondering if anyone could comment on the use
 of synthetic RNAs for crystallization. Specifically, what is the longest
 synthetic RNA that can be used for crystallization trials? I've seen some
 structures in the PDB that are up to 88 bases and are reported to have been
 obtained with synthetic constructs (3OWI - glycine riboswitch), but I don't
 really know if that's routine or if it's an exceptional case. Also, for
 those who have experience with the use of synthetic RNAs, I was wondering
 where people generally order their synthetic constructs from? Our resident
 expert in RNA crystallography recommended a company called Dharmacon (part
 of ThermoFisher), but I was hoping that I might get some other opinions as
 to which companies make the best quality oligonucleotides, provide samples
 with the highest purity, and have the most reasonable prices.

 Thanks in advance for the help!

 Mike



 --
 Michael C. Thompson

 Graduate Student

 Biochemistry  Molecular Biology Division

 Department of Chemistry  Biochemistry

 University of California, Los Angeles

 mi...@chem.ucla.edu




-- 
Mario Sanches
Postdoctoral Fellow
Samuel Lunenfeld Research Institute
Mount Sinai Hospital
600 University Ave
Toronto - Ontario
Canada
M5G 1X5
http://ca.linkedin.com/in/mariosanches


Re: [ccp4bb] Synthetic RNA for Crystallization

2011-03-13 Thread Martin Hällberg
Hi,

I'll second Israels's comment. Since the yield per coupling in synthesis is 
lower for RNA than for DNA it gets really expensive over 30-35 nucleotides.
However, you can stitch together several 30 nt oligos using either T4 RNA 
ligase or T4 DNA ligase (with a DNA splint). 
Regarding suppliers of synthetic RNA, Dharmacon is still very reliable in terms 
of actual delivered amount and quality. If you are going for very large scale 
then oligofactory.com is a good choice. 

For a 90 nt oligo without any modifications I'd definitely go for T7 in-vitro 
transcription. On top of Nagai's classic that Israel referred to, I can also 
recommend the more recent method of native purification developed by Robert 
Batey and Jeffrey Kieft. 

See:
Batey, R.T.  Kieft, J.S. Improved native affinity purification of RNA (2007) 
RNA, 13, 1384-1389.

You are going to need milligrams of T7 RNA polymerase in the end so forget 
about transcription kits, make your own.

Cheers,

Martin


On Mar 13, 2011, at 10:16 AM, Israel Sanchez wrote:

 Hi Michael,
 
 
 
 we normally produce synthetic RNAs following this classic paper if the size 
 is more than let say 40-50 nucleotide, otherwise we buy the RNAs from 
 Dharmacon and the quality is totally OK. 
 Hope it helps
 
 
 
 
 
 J Mol Biol. 1995 Jun 2;249(2):398-408.
 
 Crystallization of RNA-protein complexes. I. Methods for the large-scale 
 preparation of RNA suitable for crystallographic studies.
 
 Price SR, Ito N, Oubridge C, Avis JM, Nagai K.
 
 MRC Laboratory of Molecular Biology, Cambridge, UK.
 
 Abstract
 
 In vitro transcription using bacteriophage RNA polymerases and linearised 
 plasmid or oligodeoxynucleotide templates has been used extensively to 
 produce RNA for biochemical studies. This method is, however, not ideal for 
 generating RNA for crystallisation because efficient synthesis requires the 
 RNA to have a purine rich sequence at the 5' terminus, also the subsequent 
 RNA is heterogenous in length. We have developed two methods for the large 
 scale production of homogeneous RNA of virtually any sequence for 
 crystallization. In the first method RNA is transcribed together with two 
 flanking intramolecularly-, (cis-), acting ribozymes which excise the desired 
 RNA sequence from the primary transcript, eliminating the promoter sequence 
 and heterogeneous 3' end generated by run-off transcription. We use a 
 combination of two hammerhead ribozymes or a hammerhead and a hairpin 
 ribozyme. The RNA-enzyme activity generates few sequence restrictions at the 
 3' terminus and none at the 5' terminus, a considerable improvement on 
 current methodologies. In the second method the BsmAI restriction 
 endonuclease is used to linearize plasmid template DNA thereby allowing the 
 generation of RNA with any 3' end. In combination with a 5' cis-acting 
 hammerhead ribozyme any sequence of RNA may be generated by in vitro 
 transcription. This has proven to be extremely useful for the synthesis of 
 short RNAs.
 
 
 
 2011/3/13 Michael Thompson mi...@chem.ucla.edu
 Hello All,
 
 I am looking for some advice from some experienced RNA crystallographers. I 
 would like to order some relatively short (90 bases) synthetic RNAs for 
 crystallization trials. I was wondering if anyone could comment on the use of 
 synthetic RNAs for crystallization. Specifically, what is the longest 
 synthetic RNA that can be used for crystallization trials? I've seen some 
 structures in the PDB that are up to 88 bases and are reported to have been 
 obtained with synthetic constructs (3OWI - glycine riboswitch), but I don't 
 really know if that's routine or if it's an exceptional case. Also, for those 
 who have experience with the use of synthetic RNAs, I was wondering where 
 people generally order their synthetic constructs from? Our resident expert 
 in RNA crystallography recommended a company called Dharmacon (part of 
 ThermoFisher), but I was hoping that I might get some other opinions as to 
 which companies make the best quality oligonucleotides, provide samples with 
 the highest purity, and have the most reasonable prices.
 
 Thanks in advance for the help!
 
 Mike
 
 
 
 --
 Michael C. Thompson
 
 Graduate Student
 
 Biochemistry  Molecular Biology Division
 
 Department of Chemistry  Biochemistry
 
 University of California, Los Angeles
 
 mi...@chem.ucla.edu
 
 
 
 -- 
  Israel Sanchez Fernandez PhD
 Ramakrishnan-lab
 MRC Laboratory of Molecular Biology,
 Hills Road, Cambridge, CB2 0QH, UK
 
 


[ccp4bb] MOSFILM

2011-03-13 Thread REX PALMER
Is MOSFILM 6.2.6 the latest version?
 
Rex Palmer
Birkbeck College

Re: [ccp4bb] MOSFILM

2011-03-13 Thread Albert Guskov
According to Harry Powell's website:

The current version of Mosflm is version 7.0.7 (uploaded onto this site 22nd
December 2010).

link: http://www.mrc-lmb.cam.ac.uk/harry/mosflm
Cheers,
Albert
2011/3/13 REX PALMER rex.pal...@btinternet.com

 Is MOSFILM 6.2.6 the latest version?

 Rex Palmer
 Birkbeck College



Re: [ccp4bb] MOSFILM

2011-03-13 Thread Andrew Leslie
Dear Rex,

As Albert has already pointed out, the latest version is 7.0.7 and can be
downloaded from:

http://www.mrc-lmb.cam.ac.uk/harry/mosflm/

6.2.6 dates from about 2006 I think. It will not deal with Pilatus
detectors and there have been a very large number of improvements since
then.

For ease of use, we would also strongly recommend using the new mosflm
interface (iMosflm) which can be downloaded from the same site.

Best wishes,

Andrew Leslie


 Is MOSFILM 6.2.6 the latest version?
  
 Rex Palmer
 Birkbeck College


[ccp4bb] MOSFLM

2011-03-13 Thread REX PALMER
Thanks to all for your prompt, detailed and useful answers.
I thought you would all be watching the rugby this afternoon!
 
Rex
 

[ccp4bb] Hideaki Niwa

2011-03-13 Thread REX PALMER
Does anyone have an email address for Hide Niwa who was at Birkbeck in the 
1990's and went to work back in Japan as a protein crystallographer? The 
earthquake is rather worrying.
 
Rex Palmer
Birkbeck College

Re: [ccp4bb] mosflm gain

2011-03-13 Thread Andrew Leslie
Dear James,

 Many thanks for the detailed explanation. I do find
your results very interesting  and (when time allows
!) I will certainly investigate this effect in more
detail and see if I find similar results for data
that shows significant levels of radiation damage (as
mine invariably seem to do). I have to admit that it
is not entirely clear to me why PSF would result in a
correlation between SDFAC and SDADD, although this is
clearly what you see. It would be rewarding to get to
the bottom of this. As I mentioned earlier, Phil
Evans is currently looking at the refinement of the
SD parameters in relation to Aimless (the imminent
replacement for SCALA) so he is also very interested
in figuring out exactly what is going on here (but
does not have any answers as yet).

Best wishes,

Andrew


 Andrew!  You don't believe me?  Well, I suppose it serves me right for
 not explaining where the idea came from (see below).

   I do, however, agree with Andrew's assessment that the default-chosen
 gain in MOSFLM is adequate for all practical purposes.  Any error in
 GAIN will be almost exactly compensated for by a corresponding change in
 Sdfac in SCALA, and the final value of sigma(I) will be essentially the
 same.  The only possible difference will be in the sigma-based outlier
 rejection within MOSFLM, but since the typical errors in the sigma are
 only ~30%, I predict it will be hard to find a situation where this
 makes or breaks a structure determination.

 So, by way of explanation: there are three things that led me to this
 conclusion:
 1) the control: fake data with all pixels independent.
  adjusting the GAIN as MOSFLM recommends from the BGRATIO analysis
 does, in fact, reproduce the correct value of the gain used to
 generate the fake data.  In SCALA, Sdfac refines to ~1.0, SdB refines to
 0, and Sdadd refines to the actual magnitude of fractional error
 (introduced by beam flicker, shutter jitter, etc.).  No surprises here.
 2) blur the fake data with the point-spread function (PSF) empirically
 derived for my detector
  In this case, the MOSFLM-refined gain is too low.  In SCALA,
 Sdfac refines to ~1.3, SdB refines to 3-5, and Sdadd is a bit low.
 These parameters are about what I see processing good real data.
 3) use real data, but force MOSFLM to use the GAIN calibrated
 independently for the detector
 MOSFLM grumbles a lot about the BGRATIO.  In SCALA, Sdfac refines to
 ~1, and SdB refines to ~0.  Sdadd is consistent with my
 independently-measured fractional error sources.

 Now, I have not evaluated this approach on a huge number of data sets,
 but in this case the PSF was both necessary and sufficient to explain
 the mystery of SdB.  That is: the need for SdB arises because using an
 incorrect gain creates a correlation between Sdfac and Sdadd.  I
 imagine there are other ways to get a non-zero SdB as well, but for
 good data I suspect this is the dominant mechanism.  I never wrote
 this up because I am fairly certain the article would do nothing to
 improve the impact factor of the journal in which it was published, but
 this anecdote might perhaps be useful to Andrew, Phil, and a few other
 readers of this list.

 -James Holton
 MAD Scientist


 On 3/7/2011 2:00 AM, A Leslie wrote:


 I have to say that I don't fully agree with James' recommendation to
 adjust the GAIN in MOSFLM until the calculated SDFAC parameter in
 SCALA is 1.0.

 (Background information, the sigmas from Mosflm sd(I) are corrected in
 SCALA according to
sd(I) corrected = SdFac * sqrt{sd(I)**2 + SdB*Ihl +
 (SdAdd*Ihl)**2}
 in order to get the best agreement between corrected sigmas and the
 observed differences between symmtery/Friedel related intensities)


 While I fully agree with his argument that systematic errors such as
 absorption, etc give an error proportional to the intensity, and
 therefore should be corrected by the SDADD term rather than SDFAC, in
 any real world data set that I have come across the situation is not
 so simple. Indeed, according to the usual treatment of errors there
 should be no need for the SDB term in SCALA, but in practice it is
 essential to have this term to be able to match corrected sigmas with
 the observed differences between symmetry related reflections. It also
 turns out that the three variable parameters SDFAC, SDB and SDADD are
 highly correlated, so one can get rather different values for any
 individual parameter from very similar datasets. Radiation damage is
 certainly one source of error which would not be expected to follow a
 simple error model, or non-isomorphism if multiple crystals have been
 used.

 Phil Evans is not entirely happy with the behaviour of the refinement
 of these parameters and is in fact currently looking at this, but
 there is a  basic problem here that one is trying to use a simple
 error model for a situation where (for whatever reason) it does not
 really apply.

 The sigma estimates from MOSFLM are 

Re: [ccp4bb] Hideaki Niwa

2011-03-13 Thread Hideaki Niwa
Hello Rex,

Nice to hear from you. My contact address hasn't changed
since we communicated the last time.
I'm okay in Yokohama near Tokyo, though we are facing the
grim news and our sympathy goes to those who have suffered
in the recent quake.
Let's talk off the list.

Sincerely,

Hideaki Niwa

RIKEN Systems and Structural Biology Center(SSBC)
1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa
230-0045, Japan

 Does anyone have an email address for Hide Niwa who was at Birkbeck in
the
 1990's and went to work back in Japan as a protein crystallographer? The
 earthquake is rather worrying.
 #160;
 Rex Palmer
 Birkbeck College


[ccp4bb] Postdoctoral position in Cryo-EM and structure determination

2011-03-13 Thread Stoilova-McPhie, Svetla
A postdoctoral position in Cryo-EM and structure analysis is available at the 
University of Texas Medical Branch at Galveston to study the structure and 
active conformations of membrane-associated protein and complexes involved in 
blood coagulation: http://www.utmb.edu/ncb/faculty/Stoilova-McPhieSvetla.asp. 
Highly motivated candidates with expertise in macromolecular structure 
analysis, modeling and biophysics are encouraged to apply. Additional 
experience with Linux computing systems will be an advantage. 
The Sealy Center for Structural Biology and Molecular Biophysics at UTMB, as 
well as the PI’s lab are fully equipped for state of the art structure 
determination of macromolecular complexes: http://www.scsb.utmb.edu/. UTMB is 
part of the Gulf Coast Consortium: http://cohesion.rice.edu/centersandinst/gcc/ 
and the Texas Medical Center, which houses the NIH funded National center for 
Macromolecular Imaging: http://ncmi.bcm.edu/ncmi/.

Svetla Stoilova-McPhie, PhD
Assistant Professor,
Department of Neuroscience and Cell Biology
Scientist, Sealy Centre for Structural Biology
and Molecular Biophysics
University of Texas Medical Branch at Galveston
301 University Boulevard, Galveston, Texas 77555-0620
Lab: (+1) 409-747-2159
Cell: (+1) 979-319-1348
Fax: (1+) 409-747-2200
Email: svmcp...@utmb.edu
http://www.utmb.edu/ncb/faculty/Stoilova-McPhieSvetla.asp